交易 Olema Pharmaceuticals, Inc. - OLMA CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.07 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Mar 28, 2024 | 11.29 | 0.30 | 2.73% | 10.99 | 11.45 | 10.75 |
Mar 27, 2024 | 11.13 | 0.16 | 1.46% | 10.97 | 11.40 | 10.85 |
Mar 26, 2024 | 10.90 | -0.26 | -2.33% | 11.16 | 11.22 | 10.86 |
Mar 25, 2024 | 10.94 | 0.07 | 0.64% | 10.87 | 11.30 | 10.74 |
Mar 22, 2024 | 11.19 | -0.10 | -0.89% | 11.29 | 11.50 | 11.11 |
Mar 21, 2024 | 11.52 | -0.10 | -0.86% | 11.62 | 11.73 | 11.18 |
Mar 20, 2024 | 11.61 | 0.26 | 2.29% | 11.35 | 11.67 | 11.09 |
Mar 19, 2024 | 11.53 | 0.66 | 6.07% | 10.87 | 11.81 | 10.62 |
Mar 18, 2024 | 11.06 | -0.41 | -3.57% | 11.47 | 11.57 | 10.92 |
Mar 15, 2024 | 11.50 | -0.13 | -1.12% | 11.63 | 12.05 | 11.13 |
Mar 14, 2024 | 11.53 | -0.69 | -5.65% | 12.22 | 12.49 | 11.17 |
Mar 13, 2024 | 12.47 | 0.35 | 2.89% | 12.12 | 13.48 | 12.12 |
Mar 12, 2024 | 12.09 | -0.64 | -5.03% | 12.73 | 13.11 | 11.68 |
Mar 11, 2024 | 12.96 | 0.27 | 2.13% | 12.69 | 13.73 | 12.69 |
Mar 8, 2024 | 12.97 | -1.03 | -7.36% | 14.00 | 14.35 | 12.80 |
Mar 7, 2024 | 14.05 | -0.35 | -2.43% | 14.40 | 14.58 | 13.50 |
Mar 6, 2024 | 14.25 | 0.43 | 3.11% | 13.82 | 14.53 | 13.67 |
Mar 5, 2024 | 13.80 | -0.49 | -3.43% | 14.29 | 14.54 | 13.43 |
Mar 4, 2024 | 14.49 | -0.54 | -3.59% | 15.03 | 15.24 | 14.17 |
Mar 1, 2024 | 14.75 | 2.28 | 18.28% | 12.47 | 15.01 | 12.47 |
Olema Pharmaceuticals, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Tuesday, May 7, 2024 | ||
時間 (UTC) 10:59 | 國家 US
| 事件 Q1 2024 Olema Pharmaceuticals Inc Earnings Release Q1 2024 Olema Pharmaceuticals Inc Earnings ReleaseForecast(預報) -返回 - |
Friday, June 14, 2024 | ||
時間 (UTC) 15:00 | 國家 US
| 事件 Olema Pharmaceuticals Inc Annual Shareholders Meeting Olema Pharmaceuticals Inc Annual Shareholders MeetingForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 106.988 | 71.491 | 21.528 | 4.323 | 2.173 |
銷售/一般/行政費用,總計 | 24.714 | 20.391 | 7.824 | 0.403 | 0.386 |
研究與開發 | 82.274 | 51.1 | 13.704 | 3.92 | 1.693 |
異常費用(收入) | 0 | 0.094 | |||
營業收入 | -106.988 | -71.491 | -21.528 | -4.323 | -2.173 |
利息收入(費用),非經營淨值 | 2.228 | 0.442 | -0.593 | 0.007 | -0.024 |
其他,淨值 | -0.027 | -0.047 | 0 | 0 | |
稅前淨收入 | -104.787 | -71.096 | -22.121 | -4.316 | -2.197 |
稅後淨收入 | -104.787 | -71.096 | -22.121 | -4.316 | -2.197 |
未計算非常項目前的淨收益 | -104.787 | -71.096 | -22.121 | -4.316 | -2.197 |
淨收入 | -104.787 | -71.096 | -22.121 | -4.316 | -2.197 |
Total Adjustments to Net Income | 0 | -1.869 | 0 | 0 | |
普通股股東可獲收益 (不含非經常性項目) | -104.787 | -71.096 | -23.99 | -4.316 | -2.197 |
普通股股東可獲收益 (含非經常性項目) | -104.787 | -71.096 | -23.99 | -4.316 | -2.197 |
攤薄淨收入 | -104.787 | -71.096 | -23.99 | -4.316 | -2.197 |
攤薄後加權平均股 | 39.9955 | 39.5243 | 38.5197 | 38.5197 | 38.5197 |
扣除特別項目的每股攤薄盈利 | -2.61997 | -1.79879 | -0.6228 | -0.11205 | -0.05704 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
每股正常攤薄盈利 | -2.61997 | -1.79879 | -0.6228 | -0.11205 | -0.0546 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 21.601 | 29.602 | 27.219 | 23.222 | 33.293 |
銷售/一般/行政費用,總計 | 3.612 | 6.776 | 5.635 | 5.595 | 6.239 |
研究與開發 | 17.989 | 22.826 | 21.584 | 17.627 | 27.054 |
營業收入 | -21.601 | -29.602 | -27.219 | -23.222 | -33.293 |
利息收入(費用),非經營淨值 | 1.55 | 1.305 | 0.973 | 0.622 | 0.415 |
稅前淨收入 | -20.095 | -28.286 | -26.179 | -22.72 | -32.858 |
稅後淨收入 | -20.095 | -28.286 | -26.179 | -22.72 | -32.858 |
未計算非常項目前的淨收益 | -20.095 | -28.286 | -26.179 | -22.72 | -32.858 |
淨收入 | -20.095 | -28.286 | -26.179 | -22.72 | -32.858 |
普通股股東可獲收益 (不含非經常性項目) | -20.095 | -28.286 | -26.179 | -22.72 | -32.858 |
普通股股東可獲收益 (含非經常性項目) | -20.095 | -28.286 | -26.179 | -22.72 | -32.858 |
攤薄淨收入 | -20.095 | -28.286 | -26.179 | -22.72 | -32.858 |
攤薄後加權平均股 | 40.7203 | 40.3545 | 40.1906 | 40.0362 | 39.9182 |
扣除特別項目的每股攤薄盈利 | -0.49349 | -0.70094 | -0.65137 | -0.56749 | -0.82313 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.49349 | -0.70094 | -0.65137 | -0.56749 | -0.82313 |
其他,淨值 | -0.044 | 0.011 | 0.067 | -0.12 | 0.02 |
Total Adjustments to Net Income |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 208.899 | 290.685 | 342.137 | 0.103 | 3.242 |
現金和短期投資 | 204.421 | 287.25 | 338.549 | 0.068 | 3.149 |
現金等價物 | 23.702 | 13.812 | 338.549 | 0.068 | 3.149 |
預付的費用 | 2.655 | 3.212 | 3.439 | 0 | 0 |
其他流動資産,總計 | 1.504 | 0.223 | 0.149 | 0.035 | 0.093 |
總資産 | 215.645 | 295.945 | 342.722 | 0.132 | 3.271 |
物業/廠房/設備,總計 - 淨額 | 3.975 | 4.72 | 0.075 | 0.026 | 0.026 |
物業/廠房/設備,總計 - 總額 | 4.556 | 4.944 | 0.106 | 0.097 | |
累計折舊,總計 | -0.581 | -0.224 | -0.08 | -0.071 | |
其他長期資産,總計 | 2.771 | 0.54 | 0.51 | 0.003 | 0.003 |
流動負債總額 | 16.549 | 9.019 | 4.585 | 1.378 | 0.201 |
應付賬款 | 0.374 | 0.023 | 0.719 | 0.935 | 0.116 |
預提費用 | 16.025 | 8.53 | 3.494 | 0 | 0 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 0.15 | 0.466 | 0.372 | 0.443 | 0.085 |
負債總額 | 18.099 | 11.377 | 4.585 | 1.378 | 0.201 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
股權 | 197.546 | 284.568 | 338.137 | -1.246 | 3.07 |
Redeemable Preferred Stock | 0 | 0 | 0 | 9.348 | 9.348 |
普通股 | 0.003 | 0.003 | 0.003 | 0 | 0 |
額外實收資本 | 408.333 | 388.904 | 371.228 | 0.168 | 0.168 |
留存收益(累計赤字) | -208.977 | -104.19 | -33.094 | -10.762 | -6.446 |
總負債和股東權益 | 215.645 | 295.945 | 342.722 | 0.132 | 3.271 |
已發行普通股總數 | 40.2871 | 39.7973 | 39.3082 | 38.5197 | 38.5197 |
短期投資 | 180.719 | 273.438 | |||
其他負債,總計 | 1.55 | 2.358 | |||
其他權益,總計 | -1.813 | -0.149 | |||
應收賬款總額,淨額 | 0.319 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 282.008 | 171.509 | 189.397 | 208.899 | 225.058 |
現金和短期投資 | 276.901 | 167.444 | 185.954 | 204.421 | 222.6 |
現金等價物 | 117.407 | 34.958 | 40.918 | 23.702 | 26.804 |
短期投資 | 159.494 | 132.486 | 145.036 | 180.719 | 195.796 |
預付的費用 | 4.414 | 3.607 | 3.069 | 2.655 | 1.298 |
其他流動資産,總計 | 0.274 | 0.237 | 0.072 | 1.504 | 1.16 |
總資産 | 292.799 | 177.624 | 195.768 | 215.645 | 231.997 |
物業/廠房/設備,總計 - 淨額 | 3.614 | 3.211 | 3.6 | 3.975 | 4.168 |
物業/廠房/設備,總計 - 總額 | 4.312 | 3.955 | 4.281 | 4.556 | 4.652 |
累計折舊,總計 | -0.698 | -0.744 | -0.681 | -0.581 | -0.484 |
其他長期資産,總計 | 7.177 | 2.904 | 2.771 | 2.771 | 2.771 |
流動負債總額 | 15.966 | 14.831 | 19.41 | 16.549 | 12.552 |
應付賬款 | 2.207 | 1.625 | 0.681 | 0.374 | 0.014 |
預提費用 | 13.702 | 13.094 | 18.569 | 16.025 | 12.278 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 0.057 | 0.112 | 0.16 | 0.15 | 0.26 |
負債總額 | 17.665 | 16.041 | 20.793 | 18.099 | 14.298 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
股權 | 275.134 | 161.583 | 174.975 | 197.546 | 217.699 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
普通股 | 0.004 | 0.003 | 0.003 | 0.003 | 0.003 |
額外實收資本 | 554.231 | 419.456 | 413.213 | 408.333 | 403.168 |
留存收益(累計赤字) | -278.86 | -257.358 | -237.263 | -208.977 | -182.798 |
其他權益,總計 | -0.241 | -0.518 | -0.978 | -1.813 | -2.674 |
總負債和股東權益 | 292.799 | 177.624 | 195.768 | 215.645 | 231.997 |
已發行普通股總數 | 54.6015 | 41.3244 | 40.4383 | 40.2871 | 40.0846 |
其他負債,總計 | 1.699 | 1.21 | 1.383 | 1.55 | 1.746 |
應收賬款總額,淨額 | 0.419 | 0.221 | 0.302 | 0.319 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -104.787 | -71.096 | -22.121 | -4.316 | -2.197 |
經營活動産生的現金 | -82.065 | -50.69 | -19.866 | -3.081 | -2.176 |
經營活動産生的現金 | 0.357 | 0.163 | 0.011 | 0.009 | 0.008 |
非現金物品 | 19.343 | 17.413 | 3.749 | 0 | 0.123 |
營運資金的變化 | 3.022 | 2.83 | -1.505 | 1.226 | -0.11 |
投資活動産生的現金 | 91.479 | -275.438 | -0.056 | 0 | 0 |
資本支出 | -0.363 | -1.575 | -0.056 | 0 | 0 |
融資活動産生的現金 | 0.476 | 1.391 | 358.403 | 0 | 5.254 |
融資現金流項目 | 0 | 0 | |||
股票的發行(報廢),淨額 | 0.476 | 1.391 | 355.315 | 0 | 4.931 |
債務的發行(退還),淨額 | 0 | 3.088 | 0 | 0.323 | |
現金淨變化 | 9.89 | -324.737 | 338.481 | -3.081 | 3.078 |
其他投資現金流量項目,總計 | 91.842 | -273.863 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -28.286 | -104.787 | -78.608 | -55.888 | -23.03 |
Cash From Operating Activities | -20.391 | -82.065 | -62.354 | -44.362 | -17.903 |
Cash From Operating Activities | 0.1 | 0.357 | 0.26 | 0.169 | 0.084 |
Non-Cash Items | 4.088 | 19.343 | 14.727 | 10.315 | 5.294 |
Changes in Working Capital | 3.707 | 3.022 | 1.267 | 1.042 | -0.251 |
Cash From Investing Activities | 37.387 | 91.479 | 75.143 | 54.979 | 25.567 |
Capital Expenditures | 0 | -0.363 | -0.19 | -0.051 | -0.03 |
Other Investing Cash Flow Items, Total | 37.387 | 91.842 | 75.333 | 55.03 | 25.597 |
Net Change in Cash | 17.216 | 9.89 | 12.992 | 10.714 | 7.697 |
Cash From Financing Activities | 0.22 | 0.476 | 0.203 | 0.097 | 0.033 |
Issuance (Retirement) of Stock, Net | 0.22 | 0.476 | 0.203 | 0.097 | 0.033 |
Financing Cash Flow Items | |||||
Issuance (Retirement) of Debt, Net |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Biotechnology & Medical Research (NEC) |
780 Brannan Street
SAN FRANCISCO
CALIFORNIA 94103
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 580.000 多名交易者,選擇與 Capital.com 交易